Idorsia confirms successful closing of Pharmakon loan agreement and full repayment of New Money Facility

▤ Summary

Idorsia closed a senior secured term loan agreement of up to CHF 250 million with Pharmakon Advisors. The company received an initial CHF 150 million tranche at closing. It used part of the proceeds to fully repay the CHF 105 million drawn under its earlier New Money Facility, including fees and interest. The transaction removes near-term maturities and improves liquidity and the balance sheet. This is a financing event for a commercial-stage biopharmaceutical company, not a product or personnel announcement.

$ Funding

▦ Linked Companies